SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-050727
Filing Date
2023-09-28
Accepted
2023-09-28 16:17:28
Documents
1
Period of Report
2023-09-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4191
  Complete submission text file 0001209191-23-050727.txt   5545
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Issuer) CIK: 0001117480 (see all company filings)

IRS No.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CHIMERIX, INC., 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address
Jakeman David (Reporting) CIK: 0001780556 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35867 | Film No.: 231289909